Xpovio

Karyopharm cuts staff amid push to broaden use of blood cancer drug
BioPharma Dive
Wed, 08/2/23 - 10:38 pm
Karyopharm Therapeutics
layoffs
Xpovio
CTOS 2020 – Karyopharm seeks a solid tumour Seal of approval
EP Vantage
Mon, 11/2/20 - 11:01 pm
Karyopharm
solid tumors
Xpovio
CTOS
Karyopharm’s Xpovio Wins Second FDA Approval for DLBCL Treatment
BioSpace
Tue, 06/23/20 - 10:53 am
Karyopharm
FDA
DLBCL
Xpovio
Karyopharm posts positive data from Phase III trial of multiple myeloma drug
MedCity News
Thu, 03/5/20 - 10:56 am
Karyopharm
Multiple Myeloma
clinical trials
Xpovio
Karyopharm spotlights PhIII results after controversial FDA approval
Endpoints
Mon, 03/2/20 - 11:01 am
Karyopharm Therapeutics
Xpovio
FDA
clinical trials
Upcoming events – Karyopharm's myeloma expansion and Pfizer's biz dev news
EP Vantage
Sun, 01/5/20 - 07:11 pm
Karyopharm
Xpovio
Multiple Myeloma
Pfizer
Akcea
Ionis Pharmaceuticals
AKCEA-ANGPTL3-Lrx
Karyopharm drug tested in ‘industry-first’ approach to brain cancer
Pharmaforum
Fri, 07/12/19 - 12:05 pm
Karyopharm
Xpovio
brain cancer
Selinexor
clinical trials
glioblastoma
Karyopharm’s Xpovio nabs myeloma nod despite checkered past. But 5th line?
Fierce Pharma
Mon, 07/8/19 - 08:07 pm
Karyopharm
FDA
Multiple Myeloma
Xpovio
Selinexor
After negative panel vote, FDA approves Karyopharm's multiple myeloma drug
BioCentury
Fri, 07/5/19 - 01:36 pm
Karyopharma
Xpovio
Selinexor
FDA
Multiple Myeloma